Outlook for Gilead’s COVID-19 Treatment
April 10, 2020
41 min
Full
1,792 of 5,353
April 10, 2020
Outlook for Gilead’s COVID-19 Treatment
0:00 / 41:49
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
Bloomberg Originals Episodes Around April 10, 2020
Episode 1,792 of 5,353 — walk the feed in the order it was published.
41:49This episodeOutlook for Gilead’s COVID-19 Treatment
Summary
<p>Bloomberg News Senate Reporter Steve Dennis discusses Democrats blocking Senate Majority Leader Mitch McConnell’s push to boost small business aid. Dr. Chris Beyrer, Professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, provides a coronavirus update and breaks down how the outbreak is impacting the prison population. Bloomberg Businessweek Editor Joel Weber and Bloomberg News P&I Reporter Drake Bennett walk through Zoom going from a conferencing app to becoming the pandemic’s social network. We get caught up on Businessweek Economics with Bloomberg News Global Economics and Policy Editor Kathleen Hays and Bloomberg Economics Chief U.S. Economist Carl Riccadonna. Brian Skorney, Biotech and Pharma Analyst at Baird, shares his outlook for Gilead's Remdesivir drug as treatment for COVID-19. And we Drive to the Close with Wayne Wicker, Chief Investment Officer at Vantagepoint Investment Advisers.</p><p>Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.</p><p><br /></p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>
Episode details and artwork are published by the show’s own feed. Sentinel plays short cited excerpts and links every episode back to its publisher.